| Characterization of the novel SARS‐CoV‐2 Omicron (B. 1.1. 529) variant of concern and its global perspective SK Saxena, S Kumar, S Ansari, JT Paweska, VK Maurya, AK Tripathi, ... Journal of medical virology 94 (4), 1738-1744, 2022 | 305 | 2022 |
| Morphology, genome organization, replication, and pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) S Kumar, R Nyodu, VK Maurya, SK Saxena Coronavirus Disease 2019 (COVID-19), 23-31, 2020 | 284 | 2020 |
| Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV) S Kumar, VK Maurya, AK Prasad, MLB Bhatt, SK Saxena Virusdisease 31, 13-21, 2020 | 238 | 2020 |
| Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor VK Maurya, S Kumar, AK Prasad, MLB Bhatt, SK Saxena Virusdisease 31, 179-193, 2020 | 210 | 2020 |
| Re‐emerging human monkeypox: a major public‐health debacle SK Saxena, S Ansari, VK Maurya, S Kumar, A Jain, JT Paweska, ... Journal of medical virology 95 (1), e27902, 2023 | 127 | 2023 |
| Recombinant vaccines for COVID-19 T Yadav, N Srivastava, G Mishra, K Dhama, S Kumar, B Puri, SK Saxena Human vaccines & immunotherapeutics 16 (12), 2905-2912, 2020 | 110 | 2020 |
| Host immune response and immunobiology of human SARS-CoV-2 infection S Kumar, R Nyodu, VK Maurya, SK Saxena Coronavirus Disease 2019 (COVID-19) Epidemiology, Pathogenesis, Diagnosis …, 2020 | 109 | 2020 |
| Current advances in nanotechnology and medicine SK Saxena, R Nyodu, S Kumar, VK Maurya NanoBioMedicine, 3-16, 2020 | 49 | 2020 |
| Laboratory diagnosis of novel coronavirus disease 2019 (COVID-19) infection A Padhi, S Kumar, E Gupta, SK Saxena Coronavirus Disease 2019 (COVID-19) Epidemiology, Pathogenesis, Diagnosis …, 2020 | 48 | 2020 |
| Current insight into the novel coronavirus disease 2019 (COVID-19) SK Saxena, S Kumar, VK Maurya, R Sharma, HR Dandu, MLB Bhatt Coronavirus Disease 2019 (COVID-19) Epidemiology, Pathogenesis, Diagnosis …, 2020 | 45 | 2020 |
| Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus‐2 Omicron Variant of Concern SK Saxena, S Kumar, S Ansari, JT Paweska, VK Maurya, AK Tripathi, ... Journal of medical virology 94 (5), 2160-2166, 2022 | 44 | 2022 |
| Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection VK Maurya, S Kumar, MLB Bhatt, SK Saxena Journal of Biomolecular Structure and Dynamics 40 (4), 1719-1735, 2022 | 41 | 2022 |
| Clinical management and therapeutic strategies for the thyroid-associated ophthalmopathy: current and future perspectives S Mishra, VK Maurya, S Kumar, Ankita, A Kaur, SK Saxena Current eye research 45 (11), 1325-1341, 2020 | 39 | 2020 |
| Therapeutic Development and Drugs for the Treatment of COVID-19 VK Maurya, S Kumar, MLB Bhatt, SK Saxena Coronavirus Disease 2019 (COVID-19) Epidemiology, Pathogenesis, Diagnosis …, 2020 | 38 | 2020 |
| Viral hepatitis E and chronicity: a growing public health concern V Thakur, RK Ratho, S Kumar, SK Saxena, I Bora, P Thakur Frontiers in microbiology 11, 577339, 2020 | 37 | 2020 |
| Zika virus disease in India-update October 2018 SK Saxena, S Kumar, R Sharma, VK Maurya, HR Dandu, MLB Bhatt Travel medicine and infectious disease 27, 121-122, 2019 | 27 | 2019 |
| Tracking the COVID-19 vaccines: The global landscape T Yadav, S Kumar, G Mishra, SK Saxena Human Vaccines & Immunotherapeutics 19 (1), 2191577, 2023 | 22 | 2023 |
| Therapeutic approaches for SARS-CoV-2 infection A Gupta, A Pradhan, VK Maurya, S Kumar, A Theengh, B Puri, SK Saxena Methods 195, 29-43, 2021 | 21 | 2021 |
| Structural and molecular perspectives of SARS-CoV-2 S Kumar, SK Saxena Methods 195, 23-28, 2021 | 21 | 2021 |
| Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS: Novel drug delivery methods for NeuroAIDS S Kumar, VK Maurya, HR Dandu, MLB Bhatt, SK Saxena Biomolecular Concepts 9 (1), 33-42, 2018 | 21 | 2018 |
